/
/
/

Sai Life Sciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
₹554 Cr₹602 Cr₹556 Cr₹537 Cr₹496 Cr₹580 Cr₹440 Cr₹396 Cr₹280 Cr₹439 Cr₹384 Cr
₹4 Cr₹16 Cr₹8 Cr₹15 Cr₹10 Cr₹10 Cr₹9 Cr₹10 Cr₹8 Cr₹3 Cr₹11 Cr
₹558 Cr₹618 Cr₹565 Cr₹553 Cr₹506 Cr₹589 Cr₹449 Cr₹406 Cr₹288 Cr₹443 Cr₹395 Cr
₹452 Cr₹471 Cr₹413 Cr₹431 Cr₹413 Cr₹459 Cr₹354 Cr₹329 Cr₹285 Cr₹346 Cr₹319 Cr
₹152 Cr₹192 Cr₹196 Cr₹161 Cr₹131 Cr₹167 Cr₹129 Cr₹112 Cr₹34 Cr₹128 Cr₹108 Cr
₹8 Cr₹8 Cr₹10 Cr₹9 Cr₹12 Cr₹11 Cr₹23 Cr₹21 Cr₹21 Cr₹21 Cr₹23 Cr
₹98 Cr₹139 Cr₹134 Cr₹112 Cr₹81 Cr₹119 Cr₹72 Cr₹55 Cr-₹18 Cr₹76 Cr₹53 Cr
₹73 Cr₹104 Cr₹100 Cr₹84 Cr₹60 Cr₹88 Cr₹54 Cr₹42 Cr-₹13 Cr₹56 Cr₹40 Cr

Share Price Live Stats

Open (₹)1,570.00
Volume (₹)4.66 L
High (₹)1,622.00
Upper Circuit1,889.70
Low (₹)1,561.90
Lower Circuit1,259.90
Prev Close1,574.80
52W High (₹)1,630.00
Price1,589.10
52W Low (₹)783.85

Share Market Cap & Key Ratios Overview

M.Cap (₹)33428.70 Cr
Div. Yield (%)0.00
PE Ratio92.41
Debt to Equity0.04
Price to Book8.29
Book Value117.07
EPS (TTM)17.03
Face Value1.00
ROE (%)15.16

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
SAILIFENSE
LTP
1W Low
1W High
Market cap (₹)
1900.9-19.1 (-0.99%)
1896.80
1984.80
4,56,833Cr
9142-97 (-1.05%)
9087
9467
2,45,426Cr
4843.5-206.5 (-4.09%)
4823
5066
1,87,320Cr
1130-61 (-5.12%)
1125.10
1187
1,13,217Cr
1382.6-40.9 (-2.87%)
1376
1426.10
1,12,212Cr
1843.5-95 (-4.90%)
1811.70
1949
1,01,155Cr
2114.3-57.2 (-2.63%)
2107.20
2192
97,626Cr
2332-50.9 (-2.14%)
2327.30
2419.20
96,859Cr
1158.6-19.4 (-1.65%)
1154.40
1179.90
96,406Cr
1652.4+7.1 (0.43%)
1622.60
1717
93,614Cr
1589.1+104.1 (7.01%)
1453.20
1630
33,429Cr

Key Highlights of Sai Life Sciences Ltd’s P&L

In 2026-03-31, Sai Life Sciences Ltd reported total revenue of ₹2266.89Cr, compared with ₹1731.35Cr in 2025-03-31, reflecting Sai Life Sciences Ltd turnover.

Depreciation was ₹166.85Cr and finance costs were ₹40.88Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹466.19Cr in 2026-03-31 as compared to ₹227.7Cr in 2025-03-31.

Net Profit (PAT) was ₹348.91Cr in 2026-03-31 compared with ₹170.13Cr in 2025-03-31.

Earnings per share (EPS) were ₹16.48 in 2026-03-31, compared with ₹8.16 in 2025-03-31.